Deprecated: Required parameter $cat_id follows optional parameter $type in /www/wwwroot/ebimall.com/systems/hong.php on line 2088

Deprecated: Required parameter $where follows optional parameter $tree_id in /www/wwwroot/ebimall.com/systems/hlb.php on line 3505
Molecular Innovations/Rabbit anti mouse tPA IgG fraction/10 mg/ASMTPA-GF-10MG188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

Molecular Innovations/Rabbit anti mouse tPA IgG fraction/10 mg/ASMTPA-GF-10MG

Product Description

Rabbit anti mouse tPA IgG fraction

Polyclonal antibody (host rabbit). IgG fraction purified by immobilized Protein A.

Gene ID: 18791Swiss-Prot/UniProt ID: P11214

View sample datasheetView sample certificate of analysisView material safety data sheetAsk a question about this product

Additional Information

Purity

IgG fraction

Source

Rabbit serum

Molecular Weight

160,000

Target Molecular Weight

70,000

Extinction Coefficient

1.36

Antigen

Recombinant full length wild-type mouse protein (Glycosylated).

Epitope

Recognises Tissue Plasminogen Activator (tPA)

Cross Reactivity

Ms, Rat

Clonality

Polyclonal

Isotype

IgG

Host

Rabbit

Species

Mouse

Storage

-70 C

Shipping Conditions

Dry ice

Expiration

5 years from delivery

Form

Frozen liquid

Buffer

0.05M Sodium Phosphate; 0.1M NaCl; 1mM EDTA; pH 6.6

Sample Size

1.0 mg

Sample Concentration

10.0 mg/ml

Sample Volume

0.1 ml

Applications

ELISA, Immunohistochemistry (frozen sections), Immunoprecipitation, Western Blot

Gene Name

PLAT

Gene ID

18791

UniProt ID

P11214

1. Zaitsev S, Danielyan K, Murciano JC et-al. Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis. Blood. 2006;108 (6): 1895-902. doi:10.1182/blood-2005-11-012336 – Free text at pubmed – Pubmed citation

2. Adhami F, Yu D, Yin W et-al. Deleterious effects of plasminogen activators in neonatal cerebral hypoxia-ischemia. Am. J. Pathol. 2008;172 (6): 1704-16. doi:10.2353/ajpath.2008.070979 – Free text at pubmed – Pubmed citation

3. Sundaram JR, Chan ES, Poore CP et-al. Cdk5/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration. J. Neurosci. 2012;32 (3): 1020-34. doi:10.1523/JNEUROSCI.5177-11.2012 – Pubmed citation

4. Bi oh S, Suh N, Kim I, Lee JY. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer’s disease. Brain Res. 2015;1597:159-67. – link to article

5. Cooper JM, Rastogi A, Krizo JA, Mintz EM, Prosser RA. Urokinase-type plasminogen activator modulates mammalian circadian clock phase regulation in tissue-type plasminogen activator knockout mice. Eur J Neurosci. 2016; Link to article

6. Rzeczycki, P. The Role of Macrophages in the Sequestration of Drug and Formation of Insoluble Drug Aggregates. Link to article

7. Singh S, Houng A, Reed GL. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation. Circulation. 2017;135(11):1011-1020. Link to article

新闻动态
行业前沿
技术文章
最新产品